Related Experiment Video
Updated: Mar 1, 2026
09:29
A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
Published on: February 11, 2014
13.6K
Progress in the clinical development and utilization of vision prostheses: an update
Alice Brandli1, Chi D Luu1, Robyn H Guymer1
1Centre for Eye Research Australia, Department of Surgery (Ophthalmology), The University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Eye and Brain
|May 26, 2017
Summary
Vision prostheses, or bionic eyes, offer hope for restoring sight in individuals with blindness. This review updates on bionic eye advancements and future directions in the field.
Area of Science:
- Biomedical Engineering
- Ophthalmology
- Neuroscience
Background:
- Vision prostheses, or bionic eyes, are advanced implantable devices designed to restore partial sight.
- Significant progress has been made over the last 20 years in developing these technologies.
- Two retinal prostheses are currently available commercially in the US and Europe.
Purpose of the Study:
- To provide an updated overview of the current state of vision prosthesis development.
- To discuss the advancements in bionic eye technology.
- To explore future research directions and potential innovations in the field.
Main Methods:
- Review of current literature on vision prostheses.
- Analysis of commercially available devices and next-generation technologies.
- Discussion of clinical outcomes and technological challenges.
Main Results:
- The field of vision prostheses has seen rapid progression.
- Commercial availability of retinal prostheses in major markets.
- Ongoing development of next-generation bionic eye devices.
Conclusions:
- Vision prostheses hold significant potential for restoring rudimentary vision.
- Continued innovation is crucial for improving device efficacy and accessibility.
- Future research will likely focus on enhanced visual perception and broader clinical application.
More Related Videos
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
01:25Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
01:24Vision
60.8K
Vision is the result of light being detected and transduced into neural signals by the retina of the eye. This information is then further analyzed and interpreted by the brain. First, light enters the front of the eye and is focused by the cornea and lens onto the retina—a thin sheet of neural tissue lining the back of the eye. Because of refraction through the convex lens of the eye, images are projected onto the retina upside-down and reversed.
60.8K
01:11Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
01:23Ophthalmic Drug Delivery Systems
103
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
103